

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 5.63356202 |
| 2 | hemidesmosome assembly (GO:0031581) | 5.42767368 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.27436356 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.51684282 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.49765567 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.36185576 |
| 7 | gap junction assembly (GO:0016264) | 4.29388954 |
| 8 | semaphorin-plexin signaling pathway (GO:0071526) | 4.12091393 |
| 9 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.03405816 |
| 10 | epithelial cell-cell adhesion (GO:0090136) | 4.00354657 |
| 11 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.96911141 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.95565529 |
| 13 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.88390809 |
| 14 | vocalization behavior (GO:0071625) | 3.87562612 |
| 15 | endothelium development (GO:0003158) | 3.87360990 |
| 16 | glutamate secretion (GO:0014047) | 3.78827487 |
| 17 | cell-substrate junction assembly (GO:0007044) | 3.78430254 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.77663270 |
| 19 | negative regulation of cell fate specification (GO:0009996) | 3.73498260 |
| 20 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.68971155 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.67609495 |
| 22 | adherens junction assembly (GO:0034333) | 3.64932900 |
| 23 | regulation of cell fate specification (GO:0042659) | 3.55874976 |
| 24 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.54577362 |
| 25 | regulation of gene silencing by miRNA (GO:0060964) | 3.54577362 |
| 26 | regulation of gene silencing by RNA (GO:0060966) | 3.54577362 |
| 27 | regulation of water loss via skin (GO:0033561) | 3.54410690 |
| 28 | paraxial mesoderm development (GO:0048339) | 3.48826020 |
| 29 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.45315951 |
| 30 | multicellular organismal water homeostasis (GO:0050891) | 3.40282808 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 3.39367488 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.39367488 |
| 33 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.38453023 |
| 34 | cell-substrate adherens junction assembly (GO:0007045) | 3.36436039 |
| 35 | focal adhesion assembly (GO:0048041) | 3.36436039 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 3.31654218 |
| 37 | sodium ion export (GO:0071436) | 3.28650529 |
| 38 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.27281039 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.25110683 |
| 40 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.22703255 |
| 41 | protein complex localization (GO:0031503) | 3.21717767 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 3.21706255 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.21706255 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.21398020 |
| 45 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.20372818 |
| 46 | exploration behavior (GO:0035640) | 3.20039303 |
| 47 | synaptic vesicle exocytosis (GO:0016079) | 3.20013834 |
| 48 | endothelial cell morphogenesis (GO:0001886) | 3.19447129 |
| 49 | gamma-aminobutyric acid transport (GO:0015812) | 3.18095225 |
| 50 | drug catabolic process (GO:0042737) | 3.17969143 |
| 51 | glomerular visceral epithelial cell development (GO:0072015) | 3.16420719 |
| 52 | neurotransmitter secretion (GO:0007269) | 3.14260028 |
| 53 | alpha-linolenic acid metabolic process (GO:0036109) | 3.11253588 |
| 54 | exogenous drug catabolic process (GO:0042738) | 3.11239020 |
| 55 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.10125213 |
| 56 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.09913728 |
| 57 | glomerular epithelial cell development (GO:0072310) | 3.09302647 |
| 58 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.09255816 |
| 59 | apical protein localization (GO:0045176) | 3.08093300 |
| 60 | establishment of skin barrier (GO:0061436) | 3.06690737 |
| 61 | cellular potassium ion homeostasis (GO:0030007) | 3.05899589 |
| 62 | regulation of synapse structural plasticity (GO:0051823) | 3.04324620 |
| 63 | lymphangiogenesis (GO:0001946) | 3.03954430 |
| 64 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.02812837 |
| 65 | dendritic spine morphogenesis (GO:0060997) | 3.02694521 |
| 66 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.02587584 |
| 67 | cell communication by electrical coupling (GO:0010644) | 3.02429442 |
| 68 | proline transport (GO:0015824) | 3.02379816 |
| 69 | establishment of apical/basal cell polarity (GO:0035089) | 3.01230164 |
| 70 | glutamate metabolic process (GO:0006536) | 2.99391596 |
| 71 | surfactant homeostasis (GO:0043129) | 2.99058635 |
| 72 | activation of protein kinase A activity (GO:0034199) | 2.94627599 |
| 73 | urea metabolic process (GO:0019627) | 2.93442256 |
| 74 | urea cycle (GO:0000050) | 2.93442256 |
| 75 | alanine transport (GO:0032328) | 2.93019589 |
| 76 | activation of Rac GTPase activity (GO:0032863) | 2.92083231 |
| 77 | aromatic amino acid family catabolic process (GO:0009074) | 2.89963872 |
| 78 | negative regulation of cell fate commitment (GO:0010454) | 2.89427253 |
| 79 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.87785431 |
| 80 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.87694486 |
| 81 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.84739716 |
| 82 | cell-cell junction assembly (GO:0007043) | 2.84053314 |
| 83 | bile acid biosynthetic process (GO:0006699) | 2.83994858 |
| 84 | regulation of cholesterol homeostasis (GO:2000188) | 2.83180121 |
| 85 | convergent extension (GO:0060026) | 2.83169182 |
| 86 | kynurenine metabolic process (GO:0070189) | 2.82706031 |
| 87 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.81228292 |
| 88 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.81069448 |
| 89 | regulation of synaptic vesicle transport (GO:1902803) | 2.79271015 |
| 90 | high-density lipoprotein particle remodeling (GO:0034375) | 2.78705140 |
| 91 | protein localization to synapse (GO:0035418) | 2.77625281 |
| 92 | renal filtration (GO:0097205) | 2.77369335 |
| 93 | cellular protein complex localization (GO:0034629) | 2.77090722 |
| 94 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.75343441 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.74791459 |
| 96 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.74089017 |
| 97 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.74089017 |
| 98 | neural tube development (GO:0021915) | 2.73414851 |
| 99 | protein retention in ER lumen (GO:0006621) | 2.71493129 |
| 100 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.71185698 |
| 101 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.70268495 |
| 102 | negative regulation of fibrinolysis (GO:0051918) | 2.69304408 |
| 103 | lysine metabolic process (GO:0006553) | 2.68707222 |
| 104 | lysine catabolic process (GO:0006554) | 2.68707222 |
| 105 | chemical homeostasis within a tissue (GO:0048875) | 2.66284023 |
| 106 | cell junction assembly (GO:0034329) | 2.66186177 |
| 107 | renal system process involved in regulation of blood volume (GO:0001977) | 2.65667012 |
| 108 | adherens junction organization (GO:0034332) | 2.65264749 |
| 109 | cellular sodium ion homeostasis (GO:0006883) | 2.64484186 |
| 110 | water homeostasis (GO:0030104) | 2.63533664 |
| 111 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.63174869 |
| 112 | nitrogen cycle metabolic process (GO:0071941) | 2.61912481 |
| 113 | protein localization to endosome (GO:0036010) | 2.61539921 |
| 114 | neuromuscular process controlling balance (GO:0050885) | 2.61449139 |
| 115 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.60357312 |
| 116 | sulfur amino acid catabolic process (GO:0000098) | 2.59166034 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 2.59145411 |
| 118 | reverse cholesterol transport (GO:0043691) | 2.59101425 |
| 119 | notochord development (GO:0030903) | 2.56687703 |
| 120 | cysteine metabolic process (GO:0006534) | 2.56546044 |
| 121 | hippo signaling (GO:0035329) | 2.56336906 |
| 122 | cell-cell junction maintenance (GO:0045217) | 2.56179989 |
| 123 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.55809858 |
| 124 | endothelial cell chemotaxis (GO:0035767) | 2.55717572 |
| 125 | basement membrane organization (GO:0071711) | 2.55676207 |
| 126 | regulation of ARF protein signal transduction (GO:0032012) | 2.54758627 |
| 127 | cell junction organization (GO:0034330) | 2.54114579 |
| 128 | synaptic transmission, glutamatergic (GO:0035249) | 2.53895351 |
| 129 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.52535630 |
| 130 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.52532604 |
| 131 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.52468778 |
| 132 | tight junction assembly (GO:0070830) | 2.50527280 |
| 133 | long-term memory (GO:0007616) | 2.50382966 |
| 134 | glyoxylate metabolic process (GO:0046487) | 2.50231370 |
| 135 | positive regulation of membrane potential (GO:0045838) | 2.49858595 |
| 136 | negative regulation of sterol transport (GO:0032372) | 2.49226761 |
| 137 | negative regulation of cholesterol transport (GO:0032375) | 2.49226761 |
| 138 | indole-containing compound catabolic process (GO:0042436) | 2.48913676 |
| 139 | indolalkylamine catabolic process (GO:0046218) | 2.48913676 |
| 140 | tryptophan catabolic process (GO:0006569) | 2.48913676 |
| 141 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.48634180 |
| 142 | regulation of establishment of planar polarity (GO:0090175) | 2.48311638 |
| 143 | cellular modified amino acid catabolic process (GO:0042219) | 2.47612247 |
| 144 | ear development (GO:0043583) | 2.47597308 |
| 145 | atrioventricular valve morphogenesis (GO:0003181) | 2.47162473 |
| 146 | positive regulation of synapse maturation (GO:0090129) | 2.45843037 |
| 147 | complement activation, alternative pathway (GO:0006957) | 2.45582457 |
| 148 | asymmetric protein localization (GO:0008105) | 2.45581078 |
| 149 | cell-cell junction organization (GO:0045216) | 2.45424480 |
| 150 | glycine transport (GO:0015816) | 2.45377362 |
| 151 | bile acid metabolic process (GO:0008206) | 2.44826175 |
| 152 | regulation of fibrinolysis (GO:0051917) | 2.44728146 |
| 153 | regulation of protein activation cascade (GO:2000257) | 2.44549006 |
| 154 | non-canonical Wnt signaling pathway (GO:0035567) | 2.44454300 |
| 155 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.44097942 |
| 156 | dendrite morphogenesis (GO:0048813) | 2.44083152 |
| 157 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.42895894 |
| 158 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.42640389 |
| 159 | regulation of synaptic plasticity (GO:0048167) | 2.42457292 |
| 160 | heterochromatin organization (GO:0070828) | 2.41713273 |
| 161 | glomerular filtration (GO:0003094) | 2.41516997 |
| 162 | pre-miRNA processing (GO:0031054) | 2.41170425 |
| 163 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.40637588 |
| 164 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.40574707 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.40225921 |
| 166 | regulation of catenin import into nucleus (GO:0035412) | 2.39069940 |
| 167 | negative regulation of focal adhesion assembly (GO:0051895) | 2.38627055 |
| 168 | negative regulation of cell junction assembly (GO:1901889) | 2.38627055 |
| 169 | negative regulation of adherens junction organization (GO:1903392) | 2.38627055 |
| 170 | neurotransmitter transport (GO:0006836) | 2.38342680 |
| 171 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.37722032 |
| 172 | COPI coating of Golgi vesicle (GO:0048205) | 2.37463017 |
| 173 | Golgi transport vesicle coating (GO:0048200) | 2.37463017 |
| 174 | neuron cell-cell adhesion (GO:0007158) | 2.36796504 |
| 175 | regulation of cardioblast differentiation (GO:0051890) | 2.36492599 |
| 176 | lung-associated mesenchyme development (GO:0060484) | 2.35992753 |
| 177 | regulation of neurotransmitter levels (GO:0001505) | 2.35899378 |
| 178 | regulation of glomerular filtration (GO:0003093) | 2.35547351 |
| 179 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.35416378 |
| 180 | NADH metabolic process (GO:0006734) | 2.35321935 |
| 181 | neuron remodeling (GO:0016322) | 2.34977341 |
| 182 | glutamate receptor signaling pathway (GO:0007215) | 2.34463952 |
| 183 | protein-lipid complex remodeling (GO:0034368) | 2.34324160 |
| 184 | macromolecular complex remodeling (GO:0034367) | 2.34324160 |
| 185 | plasma lipoprotein particle remodeling (GO:0034369) | 2.34324160 |
| 186 | dicarboxylic acid catabolic process (GO:0043649) | 2.32945245 |
| 187 | chemosensory behavior (GO:0007635) | 2.31974113 |
| 188 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.31951557 |
| 189 | protein carboxylation (GO:0018214) | 2.31951557 |
| 190 | homocysteine metabolic process (GO:0050667) | 2.30200719 |
| 191 | regulation of triglyceride catabolic process (GO:0010896) | 2.29650638 |
| 192 | phosphate ion transmembrane transport (GO:0035435) | 2.29635361 |
| 193 | positive regulation of lipid catabolic process (GO:0050996) | 2.29208116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.15092025 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.76701622 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.47379521 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.70499707 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.51279757 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.40552023 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.35548836 |
| 8 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.35466852 |
| 9 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.32740033 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32145073 |
| 11 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31722683 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.26984225 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26842840 |
| 14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.25257713 |
| 15 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.21895906 |
| 16 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.19981446 |
| 17 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.19755459 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12080791 |
| 19 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.09496049 |
| 20 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.09496049 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.08599518 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05924326 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05363285 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.04821029 |
| 25 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.01442114 |
| 26 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.01032805 |
| 27 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.00396918 |
| 28 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99576712 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96801382 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94066810 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88095543 |
| 32 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87019713 |
| 33 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86723487 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86120165 |
| 35 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.84458221 |
| 36 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.84341286 |
| 37 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83623552 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83300033 |
| 39 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.78306929 |
| 40 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76955314 |
| 41 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76651690 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.73598015 |
| 43 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.72706034 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.71153279 |
| 45 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.69420062 |
| 46 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.69420062 |
| 47 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.69420062 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62710832 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58326017 |
| 50 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.58104005 |
| 51 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57921923 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57165130 |
| 53 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.55696446 |
| 54 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.55291617 |
| 55 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.53005189 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51951877 |
| 57 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50830144 |
| 58 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.50307218 |
| 59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.49256651 |
| 60 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.49119860 |
| 61 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.45002202 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.43504160 |
| 63 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.41997258 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.40580180 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40031358 |
| 66 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.38425884 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35974824 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33313175 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33173096 |
| 70 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31905602 |
| 71 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31816759 |
| 72 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31403406 |
| 73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31270012 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31253587 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29048138 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25071049 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24517412 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24324540 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23974902 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23927142 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23362413 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22809273 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21803872 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21252959 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.20906141 |
| 86 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20545690 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19746424 |
| 88 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19716461 |
| 89 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19716461 |
| 90 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.18459456 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17513227 |
| 92 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17030943 |
| 93 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.16957701 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16690641 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16161669 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15452889 |
| 97 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15378081 |
| 98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15071642 |
| 99 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.14813890 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14621371 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14562502 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13669609 |
| 103 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.13559968 |
| 104 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.12459444 |
| 105 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.11376646 |
| 106 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09370734 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08997016 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08254415 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07699873 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06362446 |
| 111 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06014132 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05574525 |
| 113 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05179196 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05100911 |
| 115 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04249012 |
| 116 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.03566345 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03109260 |
| 118 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.02996096 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02450439 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01557444 |
| 121 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01305749 |
| 122 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.01279285 |
| 123 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01043794 |
| 124 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00968081 |
| 125 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00501825 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00376952 |
| 127 | * AR_19668381_ChIP-Seq_PC3_Human | 0.99892108 |
| 128 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99166541 |
| 129 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98855742 |
| 130 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98845673 |
| 131 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98845673 |
| 132 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98442310 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98071013 |
| 134 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97768080 |
| 135 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.96766738 |
| 136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96763177 |
| 137 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96711508 |
| 138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96590867 |
| 139 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96247576 |
| 140 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95674952 |
| 141 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94716731 |
| 142 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94113565 |
| 143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92820133 |
| 144 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92763179 |
| 145 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91377732 |
| 146 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91173440 |
| 147 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.87765720 |
| 148 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86868654 |
| 149 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86036070 |
| 150 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85412392 |
| 151 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84996563 |
| 152 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84644645 |
| 153 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.83227534 |
| 154 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82634179 |
| 155 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81761566 |
| 156 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81471489 |
| 157 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81266165 |
| 158 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81118484 |
| 159 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80692369 |
| 160 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80544194 |
| 161 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.79469865 |
| 162 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.79386997 |
| 163 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78836860 |
| 164 | AR_25329375_ChIP-Seq_VCAP_Human | 0.78624325 |
| 165 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78390939 |
| 166 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77910621 |
| 167 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76607821 |
| 168 | STAT3_23295773_ChIP-Seq_U87_Human | 0.76486898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.45101549 |
| 2 | MP0005360_urolithiasis | 4.31703302 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.04296274 |
| 4 | MP0002254_reproductive_system_inflammat | 3.59416812 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.52210587 |
| 6 | MP0003941_abnormal_skin_development | 3.49152680 |
| 7 | MP0004272_abnormal_basement_membrane | 3.34508983 |
| 8 | MP0000566_synostosis | 3.04896920 |
| 9 | MP0000579_abnormal_nail_morphology | 3.04559955 |
| 10 | MP0005365_abnormal_bile_salt | 3.00728859 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.93588418 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.93478694 |
| 13 | MP0002822_catalepsy | 2.92375125 |
| 14 | MP0004270_analgesia | 2.89307035 |
| 15 | MP0001849_ear_inflammation | 2.80043935 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.76261681 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.69829487 |
| 18 | MP0000537_abnormal_urethra_morphology | 2.63390544 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.56970607 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 2.43505382 |
| 21 | MP0010030_abnormal_orbit_morphology | 2.37341162 |
| 22 | MP0005501_abnormal_skin_physiology | 2.32443980 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.30445312 |
| 24 | MP0003252_abnormal_bile_duct | 2.29786039 |
| 25 | MP0010329_abnormal_lipoprotein_level | 2.21865909 |
| 26 | MP0009745_abnormal_behavioral_response | 2.19492109 |
| 27 | MP0005409_darkened_coat_color | 2.18940692 |
| 28 | MP0004858_abnormal_nervous_system | 2.16825739 |
| 29 | MP0003880_abnormal_central_pattern | 2.12411083 |
| 30 | MP0003329_amyloid_beta_deposits | 2.00227266 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.96674476 |
| 32 | MP0002064_seizures | 1.95656381 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.95534718 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.94803946 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.91199154 |
| 36 | MP0000467_abnormal_esophagus_morphology | 1.88241095 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.87832000 |
| 38 | MP0000762_abnormal_tongue_morphology | 1.78646656 |
| 39 | MP0002098_abnormal_vibrissa_morphology | 1.76161737 |
| 40 | MP0002572_abnormal_emotion/affect_behav | 1.69537511 |
| 41 | MP0009672_abnormal_birth_weight | 1.60718526 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.57687206 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.56063030 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.56028928 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.54648848 |
| 46 | MP0009046_muscle_twitch | 1.53733707 |
| 47 | MP0010678_abnormal_skin_adnexa | 1.52185425 |
| 48 | MP0009840_abnormal_foam_cell | 1.49839008 |
| 49 | MP0001486_abnormal_startle_reflex | 1.49037455 |
| 50 | MP0003075_altered_response_to | 1.48169034 |
| 51 | MP0005332_abnormal_amino_acid | 1.47488329 |
| 52 | MP0005083_abnormal_biliary_tract | 1.47126458 |
| 53 | MP0003283_abnormal_digestive_organ | 1.45752892 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.44490164 |
| 55 | MP0005423_abnormal_somatic_nervous | 1.44328401 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.44153281 |
| 57 | MP0002272_abnormal_nervous_system | 1.40903959 |
| 58 | MP0000678_abnormal_parathyroid_gland | 1.40670607 |
| 59 | MP0002060_abnormal_skin_morphology | 1.39230337 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.34710385 |
| 61 | MP0010368_abnormal_lymphatic_system | 1.33848168 |
| 62 | MP0001879_abnormal_lymphatic_vessel | 1.33117656 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.33058393 |
| 64 | MP0004885_abnormal_endolymph | 1.32974035 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.32613119 |
| 66 | MP0001440_abnormal_grooming_behavior | 1.31804323 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.29274013 |
| 68 | MP0005275_abnormal_skin_tensile | 1.28709000 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.28428820 |
| 70 | MP0004130_abnormal_muscle_cell | 1.28279002 |
| 71 | MP0003633_abnormal_nervous_system | 1.26851005 |
| 72 | MP0003868_abnormal_feces_composition | 1.24809110 |
| 73 | MP0001216_abnormal_epidermal_layer | 1.23693312 |
| 74 | MP0000604_amyloidosis | 1.23246967 |
| 75 | MP0003195_calcinosis | 1.22682331 |
| 76 | MP0003879_abnormal_hair_cell | 1.22350417 |
| 77 | MP0000377_abnormal_hair_follicle | 1.21208277 |
| 78 | MP0010771_integument_phenotype | 1.19648402 |
| 79 | MP0002733_abnormal_thermal_nociception | 1.19405914 |
| 80 | MP0004811_abnormal_neuron_physiology | 1.17395154 |
| 81 | MP0008569_lethality_at_weaning | 1.17250719 |
| 82 | MP0002735_abnormal_chemical_nociception | 1.17081361 |
| 83 | MP0005670_abnormal_white_adipose | 1.16602377 |
| 84 | MP0001730_embryonic_growth_arrest | 1.13522765 |
| 85 | MP0003690_abnormal_glial_cell | 1.13339140 |
| 86 | MP0002697_abnormal_eye_size | 1.13225496 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 1.12745374 |
| 88 | MP0004043_abnormal_pH_regulation | 1.12117814 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 1.08409051 |
| 90 | MP0005023_abnormal_wound_healing | 1.05039532 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 1.04253650 |
| 92 | MP0000751_myopathy | 1.02655994 |
| 93 | MP0002736_abnormal_nociception_after | 1.02640299 |
| 94 | MP0008874_decreased_physiological_sensi | 1.02484547 |
| 95 | MP0005666_abnormal_adipose_tissue | 1.01506442 |
| 96 | MP0001970_abnormal_pain_threshold | 1.00333224 |
| 97 | MP0000462_abnormal_digestive_system | 0.99717715 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98161634 |
| 99 | MP0003631_nervous_system_phenotype | 0.97812079 |
| 100 | MP0005535_abnormal_body_temperature | 0.97723717 |
| 101 | MP0002557_abnormal_social/conspecific_i | 0.95435433 |
| 102 | MP0003123_paternal_imprinting | 0.94807612 |
| 103 | MP0008872_abnormal_physiological_respon | 0.94166365 |
| 104 | MP0000955_abnormal_spinal_cord | 0.92979900 |
| 105 | MP0005187_abnormal_penis_morphology | 0.90336930 |
| 106 | MP0004924_abnormal_behavior | 0.90087826 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.90087826 |
| 108 | MP0000383_abnormal_hair_follicle | 0.89799115 |
| 109 | MP0001177_atelectasis | 0.89376864 |
| 110 | MP0003984_embryonic_growth_retardation | 0.89329100 |
| 111 | MP0002138_abnormal_hepatobiliary_system | 0.89047593 |
| 112 | MP0002925_abnormal_cardiovascular_devel | 0.88750833 |
| 113 | MP0002085_abnormal_embryonic_tissue | 0.88505755 |
| 114 | MP0004085_abnormal_heartbeat | 0.88449667 |
| 115 | MP0003119_abnormal_digestive_system | 0.88024649 |
| 116 | MP0002086_abnormal_extraembryonic_tissu | 0.87996242 |
| 117 | MP0002067_abnormal_sensory_capabilities | 0.87676625 |
| 118 | MP0000778_abnormal_nervous_system | 0.87410611 |
| 119 | MP0002249_abnormal_larynx_morphology | 0.86431341 |
| 120 | MP0005380_embryogenesis_phenotype | 0.85666354 |
| 121 | MP0001672_abnormal_embryogenesis/_devel | 0.85666354 |
| 122 | MP0003091_abnormal_cell_migration | 0.85373035 |
| 123 | MP0005257_abnormal_intraocular_pressure | 0.84858426 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.84769531 |
| 125 | MP0002066_abnormal_motor_capabilities/c | 0.83893957 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.83531794 |
| 127 | MP0002088_abnormal_embryonic_growth/wei | 0.83472553 |
| 128 | MP0002184_abnormal_innervation | 0.83119376 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.82935629 |
| 130 | MP0010630_abnormal_cardiac_muscle | 0.82687606 |
| 131 | MP0002069_abnormal_eating/drinking_beha | 0.82108306 |
| 132 | MP0002084_abnormal_developmental_patter | 0.81610193 |
| 133 | MP0000609_abnormal_liver_physiology | 0.80554350 |
| 134 | MP0001915_intracranial_hemorrhage | 0.80291967 |
| 135 | MP0000627_abnormal_mammary_gland | 0.79302109 |
| 136 | MP0003806_abnormal_nucleotide_metabolis | 0.79189321 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.79161704 |
| 138 | MP0005377_hearing/vestibular/ear_phenot | 0.79103155 |
| 139 | MP0003878_abnormal_ear_physiology | 0.79103155 |
| 140 | MP0004957_abnormal_blastocyst_morpholog | 0.77791803 |
| 141 | MP0001299_abnormal_eye_distance/ | 0.77651906 |
| 142 | MP0000477_abnormal_intestine_morphology | 0.77549301 |
| 143 | MP0002078_abnormal_glucose_homeostasis | 0.77534974 |
| 144 | MP0009053_abnormal_anal_canal | 0.76424140 |
| 145 | MP0003045_fibrosis | 0.76357374 |
| 146 | MP0005166_decreased_susceptibility_to | 0.76116605 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.75377947 |
| 148 | MP0005646_abnormal_pituitary_gland | 0.75153296 |
| 149 | MP0000767_abnormal_smooth_muscle | 0.74787346 |
| 150 | MP0002090_abnormal_vision | 0.74208507 |
| 151 | MP0001765_abnormal_ion_homeostasis | 0.73290623 |
| 152 | MP0002882_abnormal_neuron_morphology | 0.72880938 |
| 153 | MP0000432_abnormal_head_morphology | 0.72221288 |
| 154 | MP0005595_abnormal_vascular_smooth | 0.71955832 |
| 155 | MP0006138_congestive_heart_failure | 0.71875319 |
| 156 | MP0002111_abnormal_tail_morphology | 0.71651656 |
| 157 | MP0001614_abnormal_blood_vessel | 0.71583933 |
| 158 | MP0000428_abnormal_craniofacial_morphol | 0.71518855 |
| 159 | MP0009703_decreased_birth_body | 0.69996373 |
| 160 | MP0009931_abnormal_skin_appearance | 0.69091929 |
| 161 | MP0003890_abnormal_embryonic-extraembry | 0.69013959 |
| 162 | MP0005165_increased_susceptibility_to | 0.68599254 |
| 163 | MP0003632_abnormal_nervous_system | 0.66322400 |
| 164 | MP0001346_abnormal_lacrimal_gland | 0.65915061 |
| 165 | MP0009379_abnormal_foot_pigmentation | 0.65520472 |
| 166 | MP0005448_abnormal_energy_balance | 0.65254913 |
| 167 | MP0003935_abnormal_craniofacial_develop | 0.64593327 |
| 168 | MP0002080_prenatal_lethality | 0.64148815 |
| 169 | MP0000230_abnormal_systemic_arterial | 0.64009370 |
| 170 | MP0003115_abnormal_respiratory_system | 0.63496819 |
| 171 | MP0003861_abnormal_nervous_system | 0.63188362 |
| 172 | MP0004215_abnormal_myocardial_fiber | 0.63118670 |
| 173 | MP0001756_abnormal_urination | 0.62094775 |
| 174 | MP0002896_abnormal_bone_mineralization | 0.62047934 |
| 175 | MP0004133_heterotaxia | 0.60483848 |
| 176 | MP0001664_abnormal_digestion | 0.59587610 |
| 177 | MP0001188_hyperpigmentation | 0.59412285 |
| 178 | MP0001340_abnormal_eyelid_morphology | 0.58346061 |
| 179 | MP0003953_abnormal_hormone_level | 0.58042376 |
| 180 | MP0002796_impaired_skin_barrier | 0.57658043 |
| 181 | MP0004233_abnormal_muscle_weight | 0.57631775 |
| 182 | MP0003693_abnormal_embryo_hatching | 0.57389766 |
| 183 | MP0004484_altered_response_of | 0.57010628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.03306138 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.47689630 |
| 3 | Focal motor seizures (HP:0011153) | 4.10061715 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.73091521 |
| 5 | Xanthomatosis (HP:0000991) | 3.57121790 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.40239842 |
| 7 | Focal seizures (HP:0007359) | 3.38521698 |
| 8 | Fragile nails (HP:0001808) | 3.38229020 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.35863089 |
| 10 | Shallow orbits (HP:0000586) | 3.35683512 |
| 11 | Selective tooth agenesis (HP:0001592) | 3.27236086 |
| 12 | Action tremor (HP:0002345) | 3.24644675 |
| 13 | Pili torti (HP:0003777) | 3.19814316 |
| 14 | Visual hallucinations (HP:0002367) | 3.17164562 |
| 15 | Hyperactive renin-angiotensin system (HP:0000841) | 3.09807062 |
| 16 | Abnormality of the lower motor neuron (HP:0002366) | 3.09391100 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 2.97563200 |
| 18 | Complement deficiency (HP:0004431) | 2.90998273 |
| 19 | Milia (HP:0001056) | 2.81642352 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 2.81116534 |
| 21 | Epidermoid cyst (HP:0200040) | 2.79545366 |
| 22 | Abnormality of the salivary glands (HP:0010286) | 2.77521620 |
| 23 | Hyperacusis (HP:0010780) | 2.76591902 |
| 24 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.72549419 |
| 25 | Aplasia of the phalanges of the hand (HP:0009802) | 2.72549419 |
| 26 | Aplasia involving bones of the extremities (HP:0009825) | 2.72549419 |
| 27 | Pterygium (HP:0001059) | 2.71717146 |
| 28 | Ketosis (HP:0001946) | 2.67013917 |
| 29 | Torticollis (HP:0000473) | 2.66894084 |
| 30 | Abnormality of nail color (HP:0100643) | 2.63267413 |
| 31 | Broad face (HP:0000283) | 2.63240684 |
| 32 | Lower limb amyotrophy (HP:0007210) | 2.62906357 |
| 33 | Abnormal social behavior (HP:0012433) | 2.62055235 |
| 34 | Impaired social interactions (HP:0000735) | 2.62055235 |
| 35 | Skull defect (HP:0001362) | 2.61916825 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.61098852 |
| 37 | Postural instability (HP:0002172) | 2.60725408 |
| 38 | Flat acetabular roof (HP:0003180) | 2.59308879 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.59110110 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.58318441 |
| 41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.57993586 |
| 42 | Ventricular fibrillation (HP:0001663) | 2.56523364 |
| 43 | Plantar hyperkeratosis (HP:0007556) | 2.55348003 |
| 44 | Chronic bronchitis (HP:0004469) | 2.54999197 |
| 45 | Broad metatarsal (HP:0001783) | 2.53912361 |
| 46 | Obstructive sleep apnea (HP:0002870) | 2.53019264 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 2.52847684 |
| 48 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.52000410 |
| 49 | Atrophic scars (HP:0001075) | 2.49942257 |
| 50 | Focal dystonia (HP:0004373) | 2.48294634 |
| 51 | Cerebral inclusion bodies (HP:0100314) | 2.47775266 |
| 52 | Generalized tonic-clonic seizures (HP:0002069) | 2.47292992 |
| 53 | Poor eye contact (HP:0000817) | 2.46751526 |
| 54 | Supranuclear gaze palsy (HP:0000605) | 2.46582422 |
| 55 | Gout (HP:0001997) | 2.45118163 |
| 56 | Ketoacidosis (HP:0001993) | 2.45052808 |
| 57 | Vertebral clefting (HP:0008428) | 2.43915766 |
| 58 | Ankyloglossia (HP:0010296) | 2.42768947 |
| 59 | Neurofibrillary tangles (HP:0002185) | 2.41878862 |
| 60 | Hyperammonemia (HP:0001987) | 2.41764912 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.40879807 |
| 62 | Hypoalphalipoproteinemia (HP:0003233) | 2.40699913 |
| 63 | Status epilepticus (HP:0002133) | 2.39524515 |
| 64 | Advanced eruption of teeth (HP:0006288) | 2.39040520 |
| 65 | Depression (HP:0000716) | 2.38828429 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.38624221 |
| 67 | Absent eyelashes (HP:0000561) | 2.37339428 |
| 68 | Esophageal varix (HP:0002040) | 2.37086296 |
| 69 | Hemiplegia (HP:0002301) | 2.36985069 |
| 70 | Onycholysis (HP:0001806) | 2.33749845 |
| 71 | Intention tremor (HP:0002080) | 2.31685934 |
| 72 | Epileptic encephalopathy (HP:0200134) | 2.30966433 |
| 73 | Distal upper limb amyotrophy (HP:0007149) | 2.30557838 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.30557838 |
| 75 | Craniofacial dystonia (HP:0012179) | 2.28207779 |
| 76 | Bundle branch block (HP:0011710) | 2.26764604 |
| 77 | Absence seizures (HP:0002121) | 2.26732209 |
| 78 | Dysdiadochokinesis (HP:0002075) | 2.25740641 |
| 79 | Neonatal onset (HP:0003623) | 2.25132919 |
| 80 | Ankle clonus (HP:0011448) | 2.23753402 |
| 81 | Choanal stenosis (HP:0000452) | 2.23215372 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.23197451 |
| 83 | Hypoglycemic coma (HP:0001325) | 2.20229403 |
| 84 | Trismus (HP:0000211) | 2.19774393 |
| 85 | Hyperventilation (HP:0002883) | 2.19557751 |
| 86 | Anxiety (HP:0000739) | 2.18667219 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18235239 |
| 88 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.17927152 |
| 89 | Increased connective tissue (HP:0009025) | 2.15017145 |
| 90 | Dysmetria (HP:0001310) | 2.14257907 |
| 91 | Protrusio acetabuli (HP:0003179) | 2.14248806 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 2.14134161 |
| 93 | Dysmetric saccades (HP:0000641) | 2.13549885 |
| 94 | Abnormal hair laboratory examination (HP:0003328) | 2.11465917 |
| 95 | Hyperglycinemia (HP:0002154) | 2.09036879 |
| 96 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06908897 |
| 97 | Abnormal vertebral ossification (HP:0100569) | 2.04616818 |
| 98 | Skin nodule (HP:0200036) | 2.04151641 |
| 99 | Cerebral aneurysm (HP:0004944) | 2.02292538 |
| 100 | Hypoplasia of dental enamel (HP:0006297) | 2.00993793 |
| 101 | Arnold-Chiari malformation (HP:0002308) | 2.00790220 |
| 102 | Hemangiomatosis (HP:0007461) | 2.00658209 |
| 103 | Arterial tortuosity (HP:0005116) | 2.00046064 |
| 104 | Fragile skin (HP:0001030) | 1.99333052 |
| 105 | Hyperglycinuria (HP:0003108) | 1.98461969 |
| 106 | Genetic anticipation (HP:0003743) | 1.98044788 |
| 107 | Coronal craniosynostosis (HP:0004440) | 1.97060137 |
| 108 | Polycythemia (HP:0001901) | 1.96948011 |
| 109 | Turricephaly (HP:0000262) | 1.96800332 |
| 110 | Hypercholesterolemia (HP:0003124) | 1.95814389 |
| 111 | Papilledema (HP:0001085) | 1.95463009 |
| 112 | Taurodontia (HP:0000679) | 1.94102796 |
| 113 | Abnormality of permanent molar morphology (HP:0011071) | 1.94102796 |
| 114 | Abnormality of the dental root (HP:0006486) | 1.94102796 |
| 115 | Dialeptic seizures (HP:0011146) | 1.93995443 |
| 116 | Cholecystitis (HP:0001082) | 1.93737593 |
| 117 | Abnormal gallbladder physiology (HP:0012438) | 1.93737593 |
| 118 | Abnormality of glycine metabolism (HP:0010895) | 1.93194068 |
| 119 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.93194068 |
| 120 | Difficulty climbing stairs (HP:0003551) | 1.93054433 |
| 121 | Right ventricular cardiomyopathy (HP:0011663) | 1.92620351 |
| 122 | Megalencephaly (HP:0001355) | 1.92083463 |
| 123 | Atonic seizures (HP:0010819) | 1.91853761 |
| 124 | Abnormal eating behavior (HP:0100738) | 1.91607478 |
| 125 | Amblyopia (HP:0000646) | 1.91321959 |
| 126 | Spastic diplegia (HP:0001264) | 1.90978115 |
| 127 | Hypotrichosis (HP:0001006) | 1.89427815 |
| 128 | Impaired vibratory sensation (HP:0002495) | 1.89355280 |
| 129 | Abnormality of complement system (HP:0005339) | 1.88925242 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.88824369 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 1.88220424 |
| 132 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.88077005 |
| 133 | Thick nail (HP:0001805) | 1.87823410 |
| 134 | Visceral angiomatosis (HP:0100761) | 1.86296588 |
| 135 | Epileptiform EEG discharges (HP:0011182) | 1.86134949 |
| 136 | Abnormality of the gastric mucosa (HP:0004295) | 1.86026077 |
| 137 | Fat malabsorption (HP:0002630) | 1.85897381 |
| 138 | Lymphangioma (HP:0100764) | 1.85232733 |
| 139 | EEG with generalized epileptiform discharges (HP:0011198) | 1.84601598 |
| 140 | Cerebral hemorrhage (HP:0001342) | 1.84600232 |
| 141 | Partial duplication of thumb phalanx (HP:0009944) | 1.83967605 |
| 142 | Tetraplegia (HP:0002445) | 1.83917992 |
| 143 | Hypsarrhythmia (HP:0002521) | 1.83426035 |
| 144 | Abnormality of oral frenula (HP:0000190) | 1.83424846 |
| 145 | Pheochromocytoma (HP:0002666) | 1.83111591 |
| 146 | Syncope (HP:0001279) | 1.83058792 |
| 147 | Aplasia cutis congenita (HP:0001057) | 1.82815696 |
| 148 | Urinary urgency (HP:0000012) | 1.81952859 |
| 149 | Ventricular tachycardia (HP:0004756) | 1.81789957 |
| 150 | Spinal cord compression (HP:0002176) | 1.80984970 |
| 151 | Sudden death (HP:0001699) | 1.80808881 |
| 152 | Abnormality of molar (HP:0011077) | 1.80290983 |
| 153 | Abnormality of molar morphology (HP:0011070) | 1.80290983 |
| 154 | Insomnia (HP:0100785) | 1.79646920 |
| 155 | Achilles tendon contracture (HP:0001771) | 1.79606938 |
| 156 | Insidious onset (HP:0003587) | 1.79440815 |
| 157 | Termporal pattern (HP:0011008) | 1.79440815 |
| 158 | Palmoplantar hyperkeratosis (HP:0000972) | 1.78605955 |
| 159 | Bronchomalacia (HP:0002780) | 1.78570969 |
| 160 | Neonatal death (HP:0003811) | 1.78542713 |
| 161 | Abnormality of the intrinsic pathway (HP:0010989) | 1.78497763 |
| 162 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77405970 |
| 163 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77192420 |
| 164 | Hypoglycemic seizures (HP:0002173) | 1.76756819 |
| 165 | Potter facies (HP:0002009) | 1.76428522 |
| 166 | Abnormality of the dental pulp (HP:0006479) | 1.73590254 |
| 167 | Urethral obstruction (HP:0000796) | 1.73367766 |
| 168 | Hyperkalemia (HP:0002153) | 1.73189868 |
| 169 | Natal tooth (HP:0000695) | 1.73167673 |
| 170 | Overriding aorta (HP:0002623) | 1.72944350 |
| 171 | Nail dystrophy (HP:0008404) | 1.72465140 |
| 172 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71561046 |
| 173 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70317894 |
| 174 | Polygenic inheritance (HP:0010982) | 1.70078739 |
| 175 | Short nail (HP:0001799) | 1.68626016 |
| 176 | Hand muscle atrophy (HP:0009130) | 1.68381439 |
| 177 | Premature rupture of membranes (HP:0001788) | 1.68309597 |
| 178 | Germ cell neoplasia (HP:0100728) | 1.67671888 |
| 179 | Palmar hyperkeratosis (HP:0010765) | 1.67599505 |
| 180 | Alopecia of scalp (HP:0002293) | 1.67255905 |
| 181 | Back pain (HP:0003418) | 1.67085711 |
| 182 | Abnormality of renin-angiotensin system (HP:0000847) | 1.66974734 |
| 183 | Spinal rigidity (HP:0003306) | 1.66713200 |
| 184 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.64053819 |
| 185 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63780864 |
| 186 | Stroke (HP:0001297) | 1.62624606 |
| 187 | Ulnar bowing (HP:0003031) | 1.58943023 |
| 188 | Acanthosis nigricans (HP:0000956) | 1.58674345 |
| 189 | Vascular tortuosity (HP:0004948) | 1.58043866 |
| 190 | Split hand (HP:0001171) | 1.57307809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 6.21783302 |
| 2 | EPHA4 | 3.72517315 |
| 3 | MAP3K9 | 3.54088082 |
| 4 | NTRK3 | 3.40140742 |
| 5 | MET | 2.98630327 |
| 6 | PRKD3 | 2.80179717 |
| 7 | SMG1 | 2.77984962 |
| 8 | DAPK2 | 2.72798305 |
| 9 | KSR2 | 2.54669542 |
| 10 | EEF2K | 2.41650421 |
| 11 | MARK1 | 2.19141160 |
| 12 | NTRK1 | 2.18918976 |
| 13 | PAK6 | 2.10709818 |
| 14 | MAP3K4 | 2.07679242 |
| 15 | MINK1 | 2.07433873 |
| 16 | CAMKK1 | 1.98303683 |
| 17 | RIPK1 | 1.89699385 |
| 18 | MAP3K2 | 1.89568050 |
| 19 | MAP2K4 | 1.88605361 |
| 20 | PAK4 | 1.82770401 |
| 21 | CDK12 | 1.75760162 |
| 22 | MAP3K10 | 1.64928295 |
| 23 | TRIB3 | 1.59322658 |
| 24 | KDR | 1.56840858 |
| 25 | CAMK1D | 1.55227972 |
| 26 | STK38 | 1.50637924 |
| 27 | NTRK2 | 1.46180654 |
| 28 | LMTK2 | 1.44755722 |
| 29 | PRKG2 | 1.42661062 |
| 30 | TAOK1 | 1.39340528 |
| 31 | TIE1 | 1.30635216 |
| 32 | LATS2 | 1.30360315 |
| 33 | RET | 1.29762891 |
| 34 | CDK5 | 1.26926584 |
| 35 | KSR1 | 1.25436801 |
| 36 | MAP3K7 | 1.21442595 |
| 37 | SIK1 | 1.14981140 |
| 38 | DAPK1 | 1.14317298 |
| 39 | PKN2 | 1.13581459 |
| 40 | TTN | 1.13237164 |
| 41 | TYRO3 | 1.13151130 |
| 42 | PRKCH | 1.10991478 |
| 43 | EPHB1 | 1.10850356 |
| 44 | PHKG1 | 1.08372261 |
| 45 | PHKG2 | 1.08372261 |
| 46 | PAK3 | 1.07009462 |
| 47 | MAP2K7 | 1.04661435 |
| 48 | ERN1 | 1.03861290 |
| 49 | FER | 1.03365979 |
| 50 | CAMK1 | 1.01941746 |
| 51 | PDGFRA | 1.01552619 |
| 52 | MAP3K1 | 1.01191534 |
| 53 | PTK2 | 0.99270885 |
| 54 | MTOR | 0.95750720 |
| 55 | LATS1 | 0.95346769 |
| 56 | PRKCG | 0.95074958 |
| 57 | INSRR | 0.94356633 |
| 58 | PTK2B | 0.93514275 |
| 59 | PDPK1 | 0.93329786 |
| 60 | SGK3 | 0.93217032 |
| 61 | TTK | 0.89404140 |
| 62 | STK11 | 0.89053203 |
| 63 | ALK | 0.88375881 |
| 64 | RPS6KA2 | 0.87688387 |
| 65 | STK24 | 0.85546298 |
| 66 | PDK1 | 0.84803005 |
| 67 | MAP3K13 | 0.84502324 |
| 68 | MST1R | 0.84047121 |
| 69 | CAMK1G | 0.82507357 |
| 70 | SGK494 | 0.82423704 |
| 71 | SGK223 | 0.82423704 |
| 72 | SIK2 | 0.81247015 |
| 73 | TESK1 | 0.79417790 |
| 74 | GRK5 | 0.78940452 |
| 75 | NEK1 | 0.75653870 |
| 76 | CAMK2A | 0.75578358 |
| 77 | FGFR2 | 0.74868834 |
| 78 | PINK1 | 0.74491729 |
| 79 | FRK | 0.74041525 |
| 80 | MAP2K1 | 0.73619696 |
| 81 | DMPK | 0.73378986 |
| 82 | EPHB2 | 0.73296834 |
| 83 | FGFR4 | 0.72968282 |
| 84 | PTK6 | 0.72069585 |
| 85 | MARK2 | 0.71328964 |
| 86 | CAMK4 | 0.70603301 |
| 87 | PDGFRB | 0.70527548 |
| 88 | ERBB2 | 0.68084607 |
| 89 | ICK | 0.67737136 |
| 90 | SGK2 | 0.67200192 |
| 91 | PRPF4B | 0.66968347 |
| 92 | BCKDK | 0.65956250 |
| 93 | FGFR1 | 0.65481641 |
| 94 | PRKCZ | 0.65062799 |
| 95 | FES | 0.64695471 |
| 96 | TAOK3 | 0.61298811 |
| 97 | ARAF | 0.57817893 |
| 98 | WNK4 | 0.57083293 |
| 99 | RPS6KB2 | 0.56888640 |
| 100 | CDC42BPA | 0.55633469 |
| 101 | SGK1 | 0.55483338 |
| 102 | IRAK3 | 0.55255726 |
| 103 | UHMK1 | 0.54817235 |
| 104 | RIPK4 | 0.54374034 |
| 105 | CAMK2B | 0.53261560 |
| 106 | DDR2 | 0.51089232 |
| 107 | RPS6KA3 | 0.50848646 |
| 108 | CDK15 | 0.50050893 |
| 109 | NEK6 | 0.49187951 |
| 110 | SCYL2 | 0.49047867 |
| 111 | BMX | 0.47260077 |
| 112 | CDK18 | 0.47250083 |
| 113 | CAMKK2 | 0.46193829 |
| 114 | CDK14 | 0.46188874 |
| 115 | ERBB4 | 0.45962687 |
| 116 | TSSK6 | 0.44598884 |
| 117 | ROCK2 | 0.44479424 |
| 118 | RAF1 | 0.44021383 |
| 119 | TNIK | 0.43941253 |
| 120 | PRKD2 | 0.43646247 |
| 121 | FYN | 0.43477476 |
| 122 | PRKD1 | 0.43437005 |
| 123 | PRKACG | 0.43291518 |
| 124 | PRKAA1 | 0.42391699 |
| 125 | MAPK12 | 0.42344282 |
| 126 | TGFBR2 | 0.42334024 |
| 127 | CAMK2G | 0.42232078 |
| 128 | MAP3K6 | 0.42230936 |
| 129 | STK38L | 0.40866452 |
| 130 | PRKCI | 0.37291187 |
| 131 | SRC | 0.36527574 |
| 132 | NME1 | 0.36117461 |
| 133 | CASK | 0.35272659 |
| 134 | MAPKAPK3 | 0.35253364 |
| 135 | MAPK10 | 0.29535955 |
| 136 | MAP3K8 | 0.29435824 |
| 137 | TAF1 | 0.29063222 |
| 138 | MAP2K2 | 0.28327364 |
| 139 | EGFR | 0.27478563 |
| 140 | BRAF | 0.26967091 |
| 141 | MAP3K3 | 0.26150466 |
| 142 | OXSR1 | 0.25689196 |
| 143 | MAPK9 | 0.25646254 |
| 144 | AKT2 | 0.24926887 |
| 145 | RPS6KL1 | 0.22058995 |
| 146 | RPS6KC1 | 0.22058995 |
| 147 | STK39 | 0.21297391 |
| 148 | ROCK1 | 0.21031921 |
| 149 | CDK7 | 0.20723972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.00411385 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63608628 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59577906 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.54743702 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 2.32331892 |
| 6 | Tight junction_Homo sapiens_hsa04530 | 2.14634439 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.12943219 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.10381582 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03103908 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.95857886 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.92429037 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71108393 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65572929 |
| 14 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.65403830 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.62867127 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62173240 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.58319975 |
| 18 | Thyroid cancer_Homo sapiens_hsa05216 | 1.56243408 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55572017 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53001936 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.47546294 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.46802736 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46622978 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.45942718 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.44088160 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41001926 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39759679 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.39637464 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.38956038 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.36226194 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35596277 |
| 32 | Focal adhesion_Homo sapiens_hsa04510 | 1.33889261 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32526599 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.32384694 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.29353644 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29133844 |
| 37 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.28021136 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.25645181 |
| 39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.24904740 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.22809978 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21673727 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20337505 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.20254355 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17136238 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.15423777 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13847952 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11677629 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11158321 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08549561 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08139910 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07919073 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.07852220 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07285202 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05594919 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.04876876 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.04617656 |
| 57 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.04192372 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00921250 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00711961 |
| 60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98203597 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.96259672 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91525847 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90855927 |
| 64 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.90614101 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89253430 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89106638 |
| 67 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88321915 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87711217 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87098246 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87040216 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86516303 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.84094752 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84051514 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.82482364 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82096517 |
| 76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81994490 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81196481 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80325684 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79515702 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77961666 |
| 81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.76799116 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.76017910 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75108344 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73980089 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73575318 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73555545 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73197599 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.73081518 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.72958854 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72856107 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72292485 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72188451 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72048183 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71953640 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71763130 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.70846403 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70442232 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.70319981 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.69632892 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69565464 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68055601 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68024258 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66446333 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66199656 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.65627500 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65548880 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64745270 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.64523016 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62837815 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.62577878 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61685990 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61524258 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61523678 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61089979 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60785701 |
| 116 | Melanogenesis_Homo sapiens_hsa04916 | 0.60719533 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60013604 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59981172 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59850329 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59568956 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57797211 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57678925 |
| 123 | Axon guidance_Homo sapiens_hsa04360 | 0.57546939 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57500067 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55885459 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55492301 |
| 127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55013069 |
| 128 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54812752 |
| 129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54477337 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54109499 |
| 131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53687053 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53339041 |
| 133 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52742356 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52203220 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51964755 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51598311 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51567115 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51069804 |
| 139 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50091536 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49338122 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.48775038 |
| 142 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48359456 |
| 143 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47684966 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47569146 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42730451 |
| 146 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42650120 |
| 147 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42548351 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42545427 |

